Non-invasive diagnostic biomarker for pancreatic islet populations
US11389106B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Oct 17, 2018 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Oct 17, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01R33/4616
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Aspects of the disclosure relate to systems and methods for obtaining and interpreting magnetic resonance spectroscopy (MRS) data obtained from the pancreas of a subject. In some embodiments, systems and methods of the disclosure relate to analyzing MRS spectra of metabolites, for example y-Aminobutyric acid (GABA), to assess pancreatic islet density and function in a subject. In some embodiments, systems and methods described by the disclosure are useful for the diagnosis and/or treatment of diseases associated with impaired pancreatic function, for example diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.